title: CSF hypocretin (Orexin) in neurological and psychiatric conditions.
authors.forename: I O
authors.initials: IO
authors.lastname: Ebrahim
authors.forename: Y K
authors.initials: YK
authors.lastname: Semra
authors.forename: S
authors.initials: S
authors.lastname: De Lacy
authors.forename: R S
authors.initials: RS
authors.lastname: Howard
authors.forename: M D
authors.initials: MD
authors.lastname: Kopelman
authors.forename: A
authors.initials: A
authors.lastname: Williams
authors.forename: M K
authors.initials: MK
authors.lastname: Sharief
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001927:Brain Diseases / Q000378:metabolism*; D002352:Carrier Proteins / Q000134:cerebrospinal fluid*; D005260:Female; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D008297:Male; D001523:Mental Disorders / Q000378:metabolism*; D008875:Middle Aged; D009479:Neuropeptides / Q000134:cerebrospinal fluid*; D000068797:Orexins; D011863:Radioimmunoassay
chemical_list: D002352:Carrier Proteins; D047908:Intracellular Signaling Peptides and Proteins; D009479:Neuropeptides; D000068797:Orexins